NEVVI Medicare utilization intelligence

← back

Provider profile

SEN, DEEPALI MD

Rheumatology · NPI 1235459504 · SAINT LOUIS, MO

2
Groups
12
Codes · 2024
16,621
Disclosed services

SEN, DEEPALI is a Rheumatology in SAINT LOUIS, MO, a member of 2 medical groups, who billed 12 distinct codes to Medicare Part B in 2024.

Groups: PHYSICAL THERAPY SPINE AND SPORTS MEDICINE LLC (BALLWIN, MO) · WASHINGTON UNIVERSITY (SAINT LOUIS, MO) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

16,621
disclosed services
12
codes billed to Medicare Part B
Prior year · CY2023 22,317 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3111 Injection, romosozumab-aqqg, 1 mg premiumpremium premiumpremium
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
J1602 Injection, golimumab, 1 mg, for intravenous use premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more premiumpremium premiumpremium
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.